名臣健康
(002919)
| 流通市值：43.59亿 | | | 总市值：43.91亿 |
| 流通股本：2.64亿 | | | 总股本：2.66亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 895,971,000.05 | 417,505,779.32 | 1,514,450,125.51 | 1,078,874,052.86 |
| 营业总成本 | 909,901,188.34 | 414,286,951.77 | 1,495,723,182.31 | 1,031,137,681.82 |
| 其他经营收益 | | | | |
| 营业利润 | -9,310,924.4 | 4,780,289.37 | 54,741,897.28 | 38,557,736.05 |
| 利润总额 | -9,445,858.31 | 4,445,211.68 | 53,630,045.95 | 37,864,696.69 |
| 净利润 | -7,518,540.56 | 8,255,048.53 | 27,801,249.12 | 42,403,252.01 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -7,518,540.56 | 8,255,048.53 | 27,801,249.12 | 42,403,252.01 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 687,145,883.72 | 726,855,446.79 | 733,273,191.68 | 593,596,932.12 |
| 非流动资产: | | | | |
| 非流动资产合计 | 539,103,213.89 | 549,199,594.22 | 551,596,564.21 | 578,535,278.36 |
| 资产总计 | 1,226,249,097.61 | 1,276,055,041.01 | 1,284,869,755.89 | 1,172,132,210.48 |
| 流动负债: | | | | |
| 流动负债合计 | 401,847,509.7 | 419,561,907.05 | 432,995,620.19 | 329,247,182.69 |
| 非流动负债: | | | | |
| 非流动负债合计 | 38,302,306.42 | 41,406,445.08 | 45,042,495.35 | 21,451,384.55 |
| 负债合计 | 440,149,816.12 | 460,968,352.13 | 478,038,115.54 | 350,698,567.24 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 789,059,180 | 816,512,742.44 | 807,340,937.03 | 821,582,661.11 |
| 股东权益合计 | 786,099,281.49 | 815,086,688.88 | 806,831,640.35 | 821,433,643.24 |
| 负债和股东权益合计 | 1,226,249,097.61 | 1,276,055,041.01 | 1,284,869,755.89 | 1,172,132,210.48 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 816,136,365.07 | 384,848,294.15 | 1,348,530,926.51 | 928,187,653.55 |
| 经营活动现金流出小计 | 779,519,845.15 | 370,848,353.13 | 1,260,877,198.4 | 888,284,849.02 |
| 经营活动产生的现金流量净额 | 36,616,519.92 | 13,999,941.02 | 87,653,728.11 | 39,902,804.53 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 338,588,359.37 | 87,229,432.19 | 375,761,815.48 | 238,666,204.95 |
| 投资活动现金流出小计 | 446,555,478.2 | 154,478,389.15 | 414,924,291.05 | 295,936,517.67 |
| 投资活动产生的现金流量净额 | -107,967,118.83 | -67,248,956.96 | -39,162,475.57 | -57,270,312.72 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 80,000,000 | 30,014,544.16 |
| 筹资活动现金流出小计 | 50,113,344.81 | 3,235,552.99 | 59,913,267.93 | 56,506,245.36 |
| 筹资活动产生的现金流量净额 | -50,113,344.81 | -3,235,552.99 | 20,086,732.07 | -26,491,701.2 |
| 汇率变动对现金及现金等价物的影响 | -1,047,491.23 | -523,753.9 | -266,222.82 | 2,464.56 |
| 现金及现金等价物净增加额 | -122,511,434.95 | -57,008,322.83 | 68,311,761.79 | -43,856,744.83 |
| 期末现金及现金等价物余额 | 114,756,244.19 | 180,259,356.31 | 237,267,679.14 | 125,099,172.52 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -122,511,434.95 | - | 68,311,761.79 | - |